A new study released to coincide with World Cancer Research Day today argues that wider access to clinical trials of new ...

Alarmed by soaring prices for cancer drugs, the leading American oncology society has devised a “value framework” to evaluate treatments by effectiveness, side effects and cost. In a clinical ...

Dr. Chirag Jani, a Phoebe Cancer Center hematologist and oncologist beloved by his patients and well-respected by his peers, has been named president of the Georgia Society of Clinical Oncology. Jani ...

Highlights include new safety and efficacy data of Barrigel™ rectal spacer, the first and only sculptable rectal spacer1-3 • ...

UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation ...

Phase 3 ENLIGHTED study enrollment completion expected by first quarter of 2025TEL AVIV, Israel, Sept. 27, 2024 (GLOBE ...

The researchers noted that multiple studies have documented substantial declines in cancer incidence across multiple types of ...

The FDA has approved osimertinib (Tagrisso) for locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) ...

Suresh S. Ramalingam, MD, FACP, FASCO, discusses the background and next steps of the LAURA study which evaluated osimertinib ...

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry ...

High CEACAM1 and low PDL1 expression in tumors, as well as their combination identified as potential biomarkers associated ...